Gateway Investment Advisers LLC Abbott Laboratories Transaction History

Gateway Investment Advisers LLC

$9 Billion
Q3 2024

A detailed history of Gateway Investment Advisers LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Gateway Investment Advisers LLC holds 547,589 shares of ABT stock, worth $64.5 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

547,589

Previous 548,162 0.1%

Holding current value

$64.5 Million

Previous $57 Million 9.61%

% of portfolio

0.69%

Previous 0.65%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$100.07 - $118.13 $57,340 - $67,688	-573 Reduced 0.1%	547,589 $62.4 Million
Q2 2024 Jul 12, 2024	SELL	$100.73 - $112.44 $307,629 - $343,391	-3,054 Reduced 0.55%	548,162 $57 Million
Q1 2024 Apr 12, 2024	SELL	$109.52 - $120.96 $1.55 Million - $1.72 Million	-14,185 Reduced 2.51%	551,216 $62.7 Million
Q4 2023 Jan 09, 2024	BUY	$90.19 - $110.4 $167,663 - $205,233	1,859 Added 0.33%	565,401 $62.2 Million
Q3 2023 Oct 19, 2023	SELL	$95.53 - $114.62 $23,309 - $27,967	-244 Reduced 0.04%	563,542 $54.6 Million
Q2 2023 Jul 13, 2023	SELL	$100.78 - $112.29 $25,195 - $28,072	-250 Reduced 0.04%	563,786 $61.5 Million
Q1 2023 Apr 11, 2023	SELL	$96.86 - $114.01 $3.96 Million - $4.66 Million	-40,882 Reduced 6.76%	564,036 $57.1 Million
Q4 2022 Jan 13, 2023	BUY	$95.06 - $111.52 $399,061 - $468,160	4,198 Added 0.7%	604,918 $0
Q3 2022 Oct 07, 2022	SELL	$96.76 - $112.03 $576,979 - $668,034	-5,963 Reduced 0.98%	600,720 $58.1 Million
Q2 2022 Jul 13, 2022	BUY	$102.07 - $123.37 $223,022 - $269,563	2,185 Added 0.36%	606,683 $65.9 Million
Q1 2022 Apr 14, 2022	SELL	$114.02 - $139.04 $1.98 Million - $2.42 Million	-17,370 Reduced 2.79%	604,498 $71.5 Million
Q4 2021 Jan 14, 2022	SELL	$115.53 - $141.46 $1.69 Million - $2.07 Million	-14,640 Reduced 2.3%	621,868 $87.5 Million
Q3 2021 Oct 22, 2021	BUY	$116.66 - $129.06 $50,863 - $56,270	436 Added 0.07%	636,508 $75.2 Million
Q2 2021 Jul 13, 2021	SELL	$105.79 - $124.53 $2.53 Million - $2.97 Million	-23,885 Reduced 3.62%	636,072 $73.7 Million
Q1 2021 Apr 14, 2021	SELL	$108.84 - $128.23 $1.13 Million - $1.33 Million	-10,380 Reduced 1.55%	659,957 $79.1 Million
Q4 2020 Jan 14, 2021	SELL	$105.0 - $114.42 $6.11 Million - $6.66 Million	-58,182 Reduced 7.99%	670,337 $73.4 Million
Q3 2020 Oct 19, 2020	SELL	$91.64 - $111.29 $5.49 Million - $6.67 Million	-59,928 Reduced 7.6%	728,519 $79.3 Million
Q2 2020 Jul 15, 2020	SELL	$76.57 - $98.0 $4.37 Million - $5.59 Million	-57,046 Reduced 6.75%	788,447 $72.1 Million
Q1 2020 Apr 13, 2020	SELL	$62.82 - $91.86 $6.75 Million - $9.86 Million	-107,376 Reduced 11.27%	845,493 $66.7 Million
Q4 2019 Jan 09, 2020	SELL	$78.51 - $87.4 $671,260 - $747,270	-8,550 Reduced 0.89%	952,869 $82.8 Million
Q3 2019 Oct 15, 2019	SELL	$81.84 - $88.74 $4.17 Million - $4.53 Million	-50,992 Reduced 5.04%	961,419 $80.4 Million
Q2 2019 Jul 17, 2019	SELL	$72.88 - $85.0 $98,242 - $114,580	-1,348 Reduced 0.13%	1,012,411 $85.1 Million
Q1 2019 Apr 10, 2019	SELL	$66.22 - $80.06 $278,124 - $336,252	-4,200 Reduced 0.41%	1,013,759 $81 Million
Q4 2018 Jan 14, 2019	BUY	$65.56 - $74.27 $256,667 - $290,767	3,915 Added 0.39%	1,017,959 $73.6 Million
Q3 2018 Oct 16, 2018	SELL	$60.81 - $73.36 $105,748 - $127,573	-1,739 Reduced 0.17%	1,014,044 $74.4 Million
Q2 2018 Jul 11, 2018	SELL	$57.57 - $63.54 $468,677 - $517,279	-8,141 Reduced 0.8%	1,015,783 $62 Million
Q1 2018 Apr 12, 2018	BUY	$56.27 - $63.62 $3.77 Million - $4.26 Million	66,999 Added 7.0%	1,023,924 $61.4 Million
Q4 2017 Jan 17, 2018	SELL	$53.68 - $57.47 $7.31 Million - $7.82 Million	-136,100 Reduced 12.45%	956,925 $54.6 Million
Q3 2017 Oct 16, 2017	BUY	$48.06 - $53.64 $52.5 Million - $58.6 Million	1,093,025	1,093,025 $58.3 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gateway Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gateway Investment Advisers LLC with notifications on news.

Account

Gateway Investment Advisers LLC Abbott Laboratories Transaction History